{"id":182777,"date":"2023-08-25T17:39:34","date_gmt":"2023-08-25T21:39:34","guid":{"rendered":"http:\/\/stateofthenation.co\/?p=182777"},"modified":"2023-08-25T17:40:26","modified_gmt":"2023-08-25T21:40:26","slug":"dont-be-deceived-by-candidate-vivek-ramaswamy","status":"publish","type":"post","link":"http:\/\/stateofthenation.co\/?p=182777","title":{"rendered":"<h1>Don&#8217;t be deceived by <i>Manchurian Candidate<\/i> Vivek Ramaswamy<\/h1>"},"content":{"rendered":"<h1>Vetting Vivek Ramaswam<\/h1>\n<h3>Former pharma exec and newfound anti-ESG crusader has substantial ties to China, the Covid industrial complex, Pfizer, Soros inc, and a track record of business calamities.<\/h3>\n<p><!--more-->JORDAN SCHACHTE<\/p>\n<p>Vivek Ramaswamy came out of nowhere, and now he\u2019s running for president.<\/p>\n<p>Like many Americans, Mr Ramaswamy popped up on my radar due to his effective and passionate voice against the ESG and DEI movements, the climate hoax, and the woke cult, for which he deserves a lot of credit.<\/p>\n<p>Yet suddenly, he\u2019s a featured television mainstay on the likes of Fox News, CNBC, and elsewhere. Over the past few months, the 37 year old has suddenly, almost improbably, captured millions of eyes and ears with his passionate and articulate declarations against these agenda items.<\/p>\n<p>On Tuesday evening, in an appearance on the Tucker Carlson Show, the pharma founder and Yale Law grad announced that he was running for president. Yes, commander in chief. Head honcho of the whole country. President of the United States!<\/p>\n<blockquote class=\"twitter-tweet\" data-width=\"550\" data-dnt=\"true\">\n<p lang=\"en\" dir=\"ltr\">Today I\u2019m launching not just a political campaign, but a cultural movement to revive American national identity itself.<a href=\"https:\/\/t.co\/LcDB04ihNQ\">https:\/\/t.co\/LcDB04ihNQ<\/a> <a href=\"https:\/\/t.co\/koRfznikcQ\">pic.twitter.com\/koRfznikcQ<\/a><\/p>\n<p>&mdash; Vivek Ramaswamy (@VivekGRamaswamy) <a href=\"https:\/\/twitter.com\/VivekGRamaswamy\/status\/1628201975232839681?ref_src=twsrc%5Etfw\">February 22, 2023<\/a><\/p><\/blockquote>\n<p><script async src=\"https:\/\/platform.twitter.com\/widgets.js\" charset=\"utf-8\"><\/script><\/p>\n<p>A man who was almost an entire unknown before 2022 has thrown his hat in the ring for the nation\u2019s highest office, so it\u2019s time to do some real vetting.<\/p>\n<p>There\u2019s so little we actually know about Vivek Ramaswamy, other than his clearly carefully crafted brand.<\/p>\n<p>Who is the real Vivek Ramaswamy? Let\u2019s get started.<\/p>\n<p><strong>Soros, the WEF, and Wikipedia edits<\/strong><\/p>\n<p>Ramaswamy was indeed nominated and selected as a World Economic Forum Young Global Leader in 2021, which is an obvious, massive red flag. However, Ramaswamy claims an alibi, explaining on social media:<\/p>\n<blockquote class=\"twitter-tweet\" data-width=\"550\" data-dnt=\"true\">\n<p lang=\"en\" dir=\"ltr\">Funny you should bring this up. The first chapter of my upcoming book in April has the \u201creceipts\u201d of my exchanges with the World Economic Forum years ago when they *repeatedly* kept trying to get me to be named. I gave them a polite \u201chell no.\u201d Reveals the games that WEF plays. <a href=\"https:\/\/t.co\/v5SVRr1p9z\">https:\/\/t.co\/v5SVRr1p9z<\/a><\/p>\n<p>&mdash; Vivek Ramaswamy (@VivekGRamaswamy) <a href=\"https:\/\/twitter.com\/VivekGRamaswamy\/status\/1628231811770855426?ref_src=twsrc%5Etfw\">February 22, 2023<\/a><\/p><\/blockquote>\n<p><script async src=\"https:\/\/platform.twitter.com\/widgets.js\" charset=\"utf-8\"><\/script><\/p>\n<p>What he has yet to explain is his longtime association with Soros, inc.<\/p>\n<p>https:\/\/twitter.com\/josh_hammer\/status\/1628208214717218817?s=20<\/p>\n<blockquote class=\"twitter-tweet\" data-width=\"550\" data-dnt=\"true\">\n<p lang=\"en\" dir=\"ltr\">Well said, George Soros:<\/p>\n<p>\u201cI consider Mr. Xi the most dangerous enemy of open societies in the world.\u201d<a href=\"https:\/\/t.co\/kg9GCZqK6v\">https:\/\/t.co\/kg9GCZqK6v<\/a><\/p>\n<p>&mdash; Vivek Ramaswamy (@VivekGRamaswamy) <a href=\"https:\/\/twitter.com\/VivekGRamaswamy\/status\/1426884152469643264?ref_src=twsrc%5Etfw\">August 15, 2021<\/a><\/p><\/blockquote>\n<p><script async src=\"https:\/\/platform.twitter.com\/widgets.js\" charset=\"utf-8\"><\/script><\/p>\n<p>For reasons unknown, Ramaswamy\u2019s Wikipedia page was recently updated that deleted information about his religion and his association with Soros, Inc.<\/p>\n<p>Writing for the Wall Street Journal in 2020, Ramaswamy unveiled his opening salvo against the WEF and BlackRock\u2019s \u201cstakeholder capitalism\u201d model. However, later in the piece, he confusingly declared: \u201cI would love to have BlackRock as a shareholder if my company ever goes public.\u201d<\/p>\n<p><strong>China<\/strong><\/p>\n<p>Ramaswamy is known for his recent tough talk on China. On Tucker Carlson\u2019s show, Ramaswamy said that as president, he would have America reorient all of its supply chains away from China.<\/p>\n<blockquote class=\"twitter-tweet\" data-width=\"550\" data-dnt=\"true\">\n<p lang=\"en\" dir=\"ltr\">Datavant boots up a big Covid-19 registry \u2014 looking to shine a light on virus spread, impact and most effective therapies <a href=\"https:\/\/t.co\/CdYCY2FLqe\">https:\/\/t.co\/CdYCY2FLqe<\/a> <a href=\"https:\/\/t.co\/6UCy93jrLr\">pic.twitter.com\/6UCy93jrLr<\/a><\/p>\n<p>&mdash; Endpoints News (@endpts) <a href=\"https:\/\/twitter.com\/endpts\/status\/1252558039321804801?ref_src=twsrc%5Etfw\">April 21, 2020<\/a><\/p><\/blockquote>\n<p><script async src=\"https:\/\/platform.twitter.com\/widgets.js\" charset=\"utf-8\"><\/script><\/p>\n<p>However, Ramaswamy was a featured speaker at a Shanghai investment conference in 2018. Moreover, he has<a href=\"https:\/\/endpts.com\/vivek-ramaswamy-strikes-again-this-time-launching-a-beijing-based-biotech-player-with-a-pipeline\/\" rel=\"\">\u00a0launched companies out of China<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.biospace.com\/article\/releases\/sinovant-sciences-company-focused-on-the-development-of-innovative-medicines-in-china-unveiled-at-event-in-beijing\/?keywords=Datavant\" rel=\"\">formed partnerships<\/a>\u00a0with Chinese firms. In one such deal, Ramaswamy\u2019s Roivant partnered with the CIVIC Group, a state-owned investment company of the Chinese government, to launch an outfit called Sinovant Sciences.<\/p>\n<div class=\"captioned-image-container\">\n<figure>\n<div class=\"image2-inset\">\n<picture><source srcset=\"https:\/\/substackcdn.com\/image\/fetch\/w_424,c_limit,f_webp,q_auto:good,fl_progressive:steep\/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Ff1372713-5f22-4fa6-a091-011cd3f6066d_1644x1286.png 424w, https:\/\/substackcdn.com\/image\/fetch\/w_848,c_limit,f_webp,q_auto:good,fl_progressive:steep\/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Ff1372713-5f22-4fa6-a091-011cd3f6066d_1644x1286.png 848w, https:\/\/substackcdn.com\/image\/fetch\/w_1272,c_limit,f_webp,q_auto:good,fl_progressive:steep\/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Ff1372713-5f22-4fa6-a091-011cd3f6066d_1644x1286.png 1272w, https:\/\/substackcdn.com\/image\/fetch\/w_1456,c_limit,f_webp,q_auto:good,fl_progressive:steep\/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Ff1372713-5f22-4fa6-a091-011cd3f6066d_1644x1286.png 1456w\" type=\"image\/webp\" sizes=\"100vw\" \/><img loading=\"lazy\" decoding=\"async\" class=\"sizing-normal\" src=\"https:\/\/substackcdn.com\/image\/fetch\/w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep\/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Ff1372713-5f22-4fa6-a091-011cd3f6066d_1644x1286.png\" sizes=\"auto, 100vw\" srcset=\"https:\/\/substackcdn.com\/image\/fetch\/w_424,c_limit,f_auto,q_auto:good,fl_progressive:steep\/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Ff1372713-5f22-4fa6-a091-011cd3f6066d_1644x1286.png 424w, https:\/\/substackcdn.com\/image\/fetch\/w_848,c_limit,f_auto,q_auto:good,fl_progressive:steep\/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Ff1372713-5f22-4fa6-a091-011cd3f6066d_1644x1286.png 848w, https:\/\/substackcdn.com\/image\/fetch\/w_1272,c_limit,f_auto,q_auto:good,fl_progressive:steep\/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Ff1372713-5f22-4fa6-a091-011cd3f6066d_1644x1286.png 1272w, https:\/\/substackcdn.com\/image\/fetch\/w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep\/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Ff1372713-5f22-4fa6-a091-011cd3f6066d_1644x1286.png 1456w\" alt=\"\" width=\"1456\" height=\"1139\" data-attrs=\"{&quot;src&quot;:&quot;https:\/\/substack-post-media.s3.amazonaws.com\/public\/images\/f1372713-5f22-4fa6-a091-011cd3f6066d_1644x1286.png&quot;,&quot;srcNoWatermark&quot;:null,&quot;fullscreen&quot;:null,&quot;imageSize&quot;:null,&quot;height&quot;:1139,&quot;width&quot;:1456,&quot;resizeWidth&quot;:null,&quot;bytes&quot;:1259336,&quot;alt&quot;:null,&quot;title&quot;:null,&quot;type&quot;:&quot;image\/png&quot;,&quot;href&quot;:null,&quot;belowTheFold&quot;:true,&quot;topImage&quot;:false,&quot;internalRedirect&quot;:null}\" \/><\/picture>\n<div class=\"image-link-expand\"><\/div>\n<\/div>\n<\/figure>\n<\/div>\n<p>As recently as February 2022, Ramaswamy\u2019s Roivant listed subsidiary companies in China, according to SEC filings.<\/p>\n<div class=\"captioned-image-container\">\n<figure>\n<div class=\"image2-inset\">\n<picture><source srcset=\"https:\/\/substackcdn.com\/image\/fetch\/w_424,c_limit,f_webp,q_auto:good,fl_progressive:steep\/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F13050993-b959-46b4-9bf3-6ee2ca713e3f_1866x762.png 424w, https:\/\/substackcdn.com\/image\/fetch\/w_848,c_limit,f_webp,q_auto:good,fl_progressive:steep\/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F13050993-b959-46b4-9bf3-6ee2ca713e3f_1866x762.png 848w, https:\/\/substackcdn.com\/image\/fetch\/w_1272,c_limit,f_webp,q_auto:good,fl_progressive:steep\/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F13050993-b959-46b4-9bf3-6ee2ca713e3f_1866x762.png 1272w, https:\/\/substackcdn.com\/image\/fetch\/w_1456,c_limit,f_webp,q_auto:good,fl_progressive:steep\/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F13050993-b959-46b4-9bf3-6ee2ca713e3f_1866x762.png 1456w\" type=\"image\/webp\" sizes=\"100vw\" \/><img loading=\"lazy\" decoding=\"async\" class=\"sizing-normal\" src=\"https:\/\/substackcdn.com\/image\/fetch\/w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep\/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F13050993-b959-46b4-9bf3-6ee2ca713e3f_1866x762.png\" sizes=\"auto, 100vw\" srcset=\"https:\/\/substackcdn.com\/image\/fetch\/w_424,c_limit,f_auto,q_auto:good,fl_progressive:steep\/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F13050993-b959-46b4-9bf3-6ee2ca713e3f_1866x762.png 424w, https:\/\/substackcdn.com\/image\/fetch\/w_848,c_limit,f_auto,q_auto:good,fl_progressive:steep\/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F13050993-b959-46b4-9bf3-6ee2ca713e3f_1866x762.png 848w, https:\/\/substackcdn.com\/image\/fetch\/w_1272,c_limit,f_auto,q_auto:good,fl_progressive:steep\/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F13050993-b959-46b4-9bf3-6ee2ca713e3f_1866x762.png 1272w, https:\/\/substackcdn.com\/image\/fetch\/w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep\/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F13050993-b959-46b4-9bf3-6ee2ca713e3f_1866x762.png 1456w\" alt=\"\" width=\"1456\" height=\"595\" data-attrs=\"{&quot;src&quot;:&quot;https:\/\/substack-post-media.s3.amazonaws.com\/public\/images\/13050993-b959-46b4-9bf3-6ee2ca713e3f_1866x762.png&quot;,&quot;srcNoWatermark&quot;:null,&quot;fullscreen&quot;:null,&quot;imageSize&quot;:null,&quot;height&quot;:595,&quot;width&quot;:1456,&quot;resizeWidth&quot;:null,&quot;bytes&quot;:531545,&quot;alt&quot;:null,&quot;title&quot;:null,&quot;type&quot;:&quot;image\/png&quot;,&quot;href&quot;:null,&quot;belowTheFold&quot;:true,&quot;topImage&quot;:false,&quot;internalRedirect&quot;:null}\" \/><\/picture>\n<div class=\"image-link-expand\"><\/div>\n<\/div>\n<\/figure>\n<\/div>\n<p>&nbsp;<\/p>\n<p><strong>Covid-19 and the mRNA gene juice<\/strong><\/p>\n<p>The biotech entrepreneur has repeatedly tried to find a niche in the gene therapy business, and therefore, he\u2019s unsurprisingly a big proponent of mRNA shots. In January 2022, he wrote an article in the\u00a0<a href=\"https:\/\/archive.is\/uO3oO\" rel=\"\">Wall Street Journal<\/a> declaring that social distancing and cloth masks work to stop viruses, but that it needed to stop so that people can avoid antigenic drift. He added, \u201cThe most important step in fighting the Covid-19 pandemic was the distribution of vaccines.\u201d<\/p>\n<blockquote class=\"twitter-tweet\" data-width=\"550\" data-dnt=\"true\">\n<p lang=\"en\" dir=\"ltr\">But new variants aren\u2019t emerging in the U.S. They\u2019re emerging in places with a higher percentage of unvaccinated individuals. Those variants are the ones that have the greatest potential to drift, and possibly shift, away from the strain that initial vaccines were designed to 7\/<\/p>\n<p>&mdash; Vivek Ramaswamy (@VivekGRamaswamy) <a href=\"https:\/\/twitter.com\/VivekGRamaswamy\/status\/1481361541773598723?ref_src=twsrc%5Etfw\">January 12, 2022<\/a><\/p><\/blockquote>\n<p><script async src=\"https:\/\/platform.twitter.com\/widgets.js\" charset=\"utf-8\"><\/script><\/p>\n<p>Ramaswamy has extensive business ties to Pfizer. Roivant, which was founded by Ramaswamy, has partnered with the taxpayer-looting pharma cartel boss on several occasions.<\/p>\n<blockquote class=\"twitter-tweet\" data-width=\"550\" data-dnt=\"true\">\n<p lang=\"en\" dir=\"ltr\">Download our free eBook &#8211; Learn how <a href=\"https:\/\/twitter.com\/pfizer?ref_src=twsrc%5Etfw\">@pfizer<\/a>, <a href=\"https:\/\/twitter.com\/Roivant?ref_src=twsrc%5Etfw\">@Roivant<\/a>  and @mAbxience accelerate their process development strategy <a href=\"https:\/\/twitter.com\/hashtag\/bioprocess?src=hash&amp;ref_src=twsrc%5Etfw\">#bioprocess<\/a><a href=\"https:\/\/t.co\/6WBQtB5NTN\">https:\/\/t.co\/6WBQtB5NTN<\/a> <a href=\"https:\/\/t.co\/6eU4cE0uFb\">pic.twitter.com\/6eU4cE0uFb<\/a><\/p>\n<p>&mdash; Cytiva (@Cytiva) <a href=\"https:\/\/twitter.com\/Cytiva\/status\/961655928864034817?ref_src=twsrc%5Etfw\">February 8, 2018<\/a><\/p><\/blockquote>\n<p><script async src=\"https:\/\/platform.twitter.com\/widgets.js\" charset=\"utf-8\"><\/script><\/p>\n<blockquote class=\"twitter-tweet\" data-width=\"550\" data-dnt=\"true\">\n<p lang=\"en\" dir=\"ltr\">Roivant, Pfizer team up on inflammatory disease drug <a href=\"https:\/\/t.co\/ex50W2QOAv\">https:\/\/t.co\/ex50W2QOAv<\/a> <a href=\"https:\/\/t.co\/MCxdGlNTrv\">pic.twitter.com\/MCxdGlNTrv<\/a><\/p>\n<p>&mdash; Reuters (@Reuters) <a href=\"https:\/\/twitter.com\/Reuters\/status\/1598457292420153345?ref_src=twsrc%5Etfw\">December 1, 2022<\/a><\/p><\/blockquote>\n<p><script async src=\"https:\/\/platform.twitter.com\/widgets.js\" charset=\"utf-8\"><\/script><\/p>\n<p>&nbsp;<\/p>\n<p>A brief search of his social media history found no evidence that Ramawswamy has ever critiqued Pfizer.<\/p>\n<p>Roivant has also\u00a0<a href=\"https:\/\/www.fiercepharma.com\/pharma\/moderna-headed-court-after-arbutus-genevant-call-infringement-patents-related-covid-19\" rel=\"\">sued<\/a>\u00a0Moderna, claiming patent infringement related to its disastrous lipid nanoparticle delivery system, which has shown to wreak havoc on the entire human body.<\/p>\n<p><strong>Business acumen<\/strong><\/p>\n<p>Ramaswamy is estimated to have a net worth of an impressive $500 million, though it\u2019s unclear how he accumulated these funds, or if that number, which is a bit outdated, currently stands. Perhaps it\u2019s from a series of business ventures through which he successfully cashed out, but the trail left behind leaves a lot to be desired.<\/p>\n<p>Sio Gene Therapies, a company founded by Ramaswamy, recently announced\u00a0<a href=\"https:\/\/www.biopharmadive.com\/news\/sio-gene-therapy-dissolve-shut-down\/638873\/\" rel=\"\">plans to dissolve<\/a>\u00a0after years of failing to advance any successful drug candidates. Once valued at billions of dollars, Sio currently has a market cap of around $30 million, as it recently failed to find a buyer for the troubled corporation.<\/p>\n<div class=\"captioned-image-container\">\n<figure>\n<div class=\"image2-inset\">\n<picture><source srcset=\"https:\/\/substackcdn.com\/image\/fetch\/w_424,c_limit,f_webp,q_auto:good,fl_progressive:steep\/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F03d55c82-0683-45fa-a3f3-8a924ced7a2d_1408x1072.png 424w, https:\/\/substackcdn.com\/image\/fetch\/w_848,c_limit,f_webp,q_auto:good,fl_progressive:steep\/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F03d55c82-0683-45fa-a3f3-8a924ced7a2d_1408x1072.png 848w, https:\/\/substackcdn.com\/image\/fetch\/w_1272,c_limit,f_webp,q_auto:good,fl_progressive:steep\/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F03d55c82-0683-45fa-a3f3-8a924ced7a2d_1408x1072.png 1272w, https:\/\/substackcdn.com\/image\/fetch\/w_1456,c_limit,f_webp,q_auto:good,fl_progressive:steep\/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F03d55c82-0683-45fa-a3f3-8a924ced7a2d_1408x1072.png 1456w\" type=\"image\/webp\" sizes=\"100vw\" \/><img loading=\"lazy\" decoding=\"async\" class=\"sizing-normal\" src=\"https:\/\/substackcdn.com\/image\/fetch\/w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep\/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F03d55c82-0683-45fa-a3f3-8a924ced7a2d_1408x1072.png\" sizes=\"auto, 100vw\" srcset=\"https:\/\/substackcdn.com\/image\/fetch\/w_424,c_limit,f_auto,q_auto:good,fl_progressive:steep\/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F03d55c82-0683-45fa-a3f3-8a924ced7a2d_1408x1072.png 424w, https:\/\/substackcdn.com\/image\/fetch\/w_848,c_limit,f_auto,q_auto:good,fl_progressive:steep\/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F03d55c82-0683-45fa-a3f3-8a924ced7a2d_1408x1072.png 848w, https:\/\/substackcdn.com\/image\/fetch\/w_1272,c_limit,f_auto,q_auto:good,fl_progressive:steep\/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F03d55c82-0683-45fa-a3f3-8a924ced7a2d_1408x1072.png 1272w, https:\/\/substackcdn.com\/image\/fetch\/w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep\/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F03d55c82-0683-45fa-a3f3-8a924ced7a2d_1408x1072.png 1456w\" alt=\"\" width=\"1408\" height=\"1072\" data-attrs=\"{&quot;src&quot;:&quot;https:\/\/substack-post-media.s3.amazonaws.com\/public\/images\/03d55c82-0683-45fa-a3f3-8a924ced7a2d_1408x1072.png&quot;,&quot;srcNoWatermark&quot;:null,&quot;fullscreen&quot;:null,&quot;imageSize&quot;:null,&quot;height&quot;:1072,&quot;width&quot;:1408,&quot;resizeWidth&quot;:null,&quot;bytes&quot;:526602,&quot;alt&quot;:null,&quot;title&quot;:null,&quot;type&quot;:&quot;image\/png&quot;,&quot;href&quot;:null,&quot;belowTheFold&quot;:true,&quot;topImage&quot;:false,&quot;internalRedirect&quot;:null}\" \/><\/picture>\n<div class=\"image-link-expand\"><\/div>\n<\/div>\n<\/figure>\n<\/div>\n<p>Roivant Sciences, founded by Ramaswamy (he was also CEO until 2021 but remained on the board), lost almost a billion dollars last year, and has lost on average $650 million each year since 2019, according to the company\u2019s\u00a0<a href=\"https:\/\/seekingalpha.com\/symbol\/ROIV\/income-statement\" rel=\"\">financial statements<\/a>. In 2018, the company was described as akin to a \u201c<a href=\"https:\/\/www.fiercebiotech.com\/roivant-lays-off-staff-reassigns-others-major-reshuffle\" rel=\"\">bloodbath<\/a>\u201d after its prized Alzheimer drug (which formed the basis for the creation of Roivant) failed clinical trials. Over the last quarter, Roivant brought in only $12 million in revenue and had a net income of negative $291.59 million. Ramaswamy\u00a0<a href=\"https:\/\/finance.yahoo.com\/news\/roivant-sciences-announces-change-board-013200844.html\" rel=\"\">stepped dow<\/a>n from the board of Roivant after announcing his presidential run, according to a company statement.<\/p>\n<p>Ramaswamy\u2019s latest venture is Strive Asset Management, which he founded in 2022 with the mission to combat the ESG agenda in corporate America. Strive has set up a series of passively managed ETFs (through which Strive takes an above average fee) in order to purchase stock in pro-ESG\/woke companies, promising to use customer\u2019s proxy voices to convince these corporations to depart from that agenda. Since its founding, Strive has\u00a0<a href=\"https:\/\/strive.com\/newsroom\/\" rel=\"\">published<\/a>\u00a0four letters to select companies asking them to change course.<\/p>\n<div class=\"captioned-image-container\">\n<figure>\n<div class=\"image2-inset\">\n<picture><source srcset=\"https:\/\/substackcdn.com\/image\/fetch\/w_424,c_limit,f_webp,q_auto:good,fl_progressive:steep\/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Ff6c33ef0-e69d-4216-9186-64b8896b83ed_2286x1296.png 424w, https:\/\/substackcdn.com\/image\/fetch\/w_848,c_limit,f_webp,q_auto:good,fl_progressive:steep\/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Ff6c33ef0-e69d-4216-9186-64b8896b83ed_2286x1296.png 848w, https:\/\/substackcdn.com\/image\/fetch\/w_1272,c_limit,f_webp,q_auto:good,fl_progressive:steep\/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Ff6c33ef0-e69d-4216-9186-64b8896b83ed_2286x1296.png 1272w, https:\/\/substackcdn.com\/image\/fetch\/w_1456,c_limit,f_webp,q_auto:good,fl_progressive:steep\/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Ff6c33ef0-e69d-4216-9186-64b8896b83ed_2286x1296.png 1456w\" type=\"image\/webp\" sizes=\"100vw\" \/><img loading=\"lazy\" decoding=\"async\" class=\"sizing-normal\" src=\"https:\/\/substackcdn.com\/image\/fetch\/w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep\/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Ff6c33ef0-e69d-4216-9186-64b8896b83ed_2286x1296.png\" sizes=\"auto, 100vw\" srcset=\"https:\/\/substackcdn.com\/image\/fetch\/w_424,c_limit,f_auto,q_auto:good,fl_progressive:steep\/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Ff6c33ef0-e69d-4216-9186-64b8896b83ed_2286x1296.png 424w, https:\/\/substackcdn.com\/image\/fetch\/w_848,c_limit,f_auto,q_auto:good,fl_progressive:steep\/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Ff6c33ef0-e69d-4216-9186-64b8896b83ed_2286x1296.png 848w, https:\/\/substackcdn.com\/image\/fetch\/w_1272,c_limit,f_auto,q_auto:good,fl_progressive:steep\/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Ff6c33ef0-e69d-4216-9186-64b8896b83ed_2286x1296.png 1272w, https:\/\/substackcdn.com\/image\/fetch\/w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep\/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Ff6c33ef0-e69d-4216-9186-64b8896b83ed_2286x1296.png 1456w\" alt=\"\" width=\"1456\" height=\"825\" data-attrs=\"{&quot;src&quot;:&quot;https:\/\/substack-post-media.s3.amazonaws.com\/public\/images\/f6c33ef0-e69d-4216-9186-64b8896b83ed_2286x1296.png&quot;,&quot;srcNoWatermark&quot;:null,&quot;fullscreen&quot;:null,&quot;imageSize&quot;:null,&quot;height&quot;:825,&quot;width&quot;:1456,&quot;resizeWidth&quot;:null,&quot;bytes&quot;:873627,&quot;alt&quot;:null,&quot;title&quot;:null,&quot;type&quot;:&quot;image\/png&quot;,&quot;href&quot;:null,&quot;belowTheFold&quot;:true,&quot;topImage&quot;:false,&quot;internalRedirect&quot;:null}\" \/><\/picture>\n<div class=\"image-link-expand\"><\/div>\n<\/div>\n<\/figure>\n<\/div>\n<p>Critics of Ramaswamy have pointed out that Strive is effectively damaging its own mission right off of the bat by first purchasing shares and proceeding to add to the value of these companies, and then later hoping to convince them by proxy letter and\/or vote to change their behaviors.<\/p>\n<p><strong>What\u2019s the real agenda?<\/strong><\/p>\n<p>It seems that Vivek Ramaswamy knows full well that he will not actually be a serious contender for president. He has already spoken about wanting to merely be able to make the debate stage. His campaign website does not discuss his platform in any detail at all. It only shares clips of his media appearances and it is largely nothing more than a donation page.<\/p>\n<p>What is Vivek Ramaswamy actually running for? First, maybe we can get some more clarity about who this man really is and what he believes.<\/p>\n<p>___<br \/>\n<a href=\"https:\/\/www.dossier.today\/p\/vetting-vivek-ramaswamy\">https:\/\/www.dossier.today\/p\/vetting-vivek-ramaswamy<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Vetting Vivek Ramaswam Former pharma exec and newfound anti-ESG crusader has substantial ties to China, the Covid industrial complex, Pfizer, Soros inc, and a track record of business calamities.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-182777","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"http:\/\/stateofthenation.co\/index.php?rest_route=\/wp\/v2\/posts\/182777","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/stateofthenation.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/stateofthenation.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/stateofthenation.co\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/stateofthenation.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=182777"}],"version-history":[{"count":0,"href":"http:\/\/stateofthenation.co\/index.php?rest_route=\/wp\/v2\/posts\/182777\/revisions"}],"wp:attachment":[{"href":"http:\/\/stateofthenation.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=182777"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/stateofthenation.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=182777"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/stateofthenation.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=182777"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}